Skip to content

PIGMENT – PDE6A gene therapy for retinitis pigmentosa

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517924-20-00
Acronym
RDC-PDE6A-01
Enrollment
9
Registered
2024-09-24
Start date
2019-09-24
Completion date
Unknown
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PDE6A-linked Retinitis Pigmentosa

Interventions

None listed

Sponsors

Universitaetsklinikum Tuebingen AöR
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026